Effectiveness of long-term treatment with SGLT2 inhibitors: real-world evidence from a specialized diabetes center

BACKGROUND: Diabetes is a progressive disease needing multiple drugs for achieving and maintaining good glycemic control. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) is a novel class of anti-diabetic agent which offers several beneficial effects. However, the long-term effectiveness in clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Thewjitcharoen, Yotsapon, Yenseung, Nalin, Malidaeng, Areeya, Nakasatien, Soontaree, Chotwanvirat, Phawinpon, Krittiyawong, Sirinate, Wanothayaroj, Ekgaluck, Himathongkam, Thep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709980/
https://www.ncbi.nlm.nih.gov/pubmed/29213337
http://dx.doi.org/10.1186/s13098-017-0297-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709980/
https://www.ncbi.nlm.nih.gov/pubmed/29213337
http://dx.doi.org/10.1186/s13098-017-0297-y

Ejemplares similares